Tag Archives: angels

RESI San Diego: Biotech & Medtech Angels Discuss their Strategy

1 Jun

By Cole Bunn, Senior Research Analyst, LSN


Angel investors are a major force at the earliest stages of financing for life science companies, and can have a great influence in startup development. As many of these individuals have been entrepreneurs and often take an operational role along with an investment, their capital, network and know-how is crucial for energizing a new venture and ensuring that the company has all its ducks in a row as it goes on to grow as a business and raise more capital.

Given the significant differences in the development and financing needs of biotech vs. medtech companies, LSN has two separate sessions which showcase active angles in each space separately.

The Biotech Angels panel will be moderated by Bernie Rudnick, Founder, Mid Atlantic Bio Angels and will feature the following panelists:

The Medtech Angels panel will be moderated by Brian Frenzel, Member, Band of Angels and will feature the following panelists:

These panel sessions will explore general topics such as how angel groups approach an investment opportunity and how best to pitch to/work with an angel investor as well as more specific topics such as how they work with other angel groups and VCs, what to expect in the diligence process, cap table issues and more.

RESI Panel Announcement: Biotech Angels Panel

12 Nov

By Christine A. Wu, Research Analyst, LSN


Angel investors have been one of the first go-to investors as an incredibly important source of capital for fundraising entrepreneurs. They provide early stage companies not only with capital, but also with experience and professional knowledge due to their unique membership composition and investment focus.

Furthermore, there is a continuing trend of angels syndicating to participate in larger investment deals with angel investor rounds growing from $800K in 2014 to over $1M to date in 2015.

LSN has assembled accredited Angel investors particularly interested in biotech therapeutics for RESI San Francisco, occurring on January 12th. The Biotech Angels Panel will be moderated by Karl Handlesman, Founder of Codon Capital, and will be joined by:

The panel will serve as an educational opportunity for scientist entrepreneurs to better understand the trends in angel investment in the bio-pharmaceutical field; the perspective of an angel when approaching a deal in the space; and the best approach to initiate dialogue with an angel investor. Angels will explain their investment preferences and their evaluation criteria, and provide overall advice in how to approach and build relationships with them. This will undoubtedly be a tremendous opportunity for biotech life science entrepreneurs to meet angel investors in person.


%d bloggers like this: